Abstract
Background
This study investigated the use of robotics to perform extended esophageal resection in a series of patients.
Methods
A total of 14 patients with a median age of 64 years underwent esophagectomy using the da Vinci robot. At presentation, there were 12 cases of cancer, staged at T2N1 (n = 2), T3N0 (n = 2), T3N1 (n = 6), T4N1 (n = 1), and M1a (n = 1); 2 cases of high-grade dysplasia; 8 cases of adenocarcinoma; and 4 cases of squamous cell cancer; as well as 2 middle third, 9 lower third, and one gastroesophageal junction tumor. Nine patients had undergone preoperative chemoradiotherapy, and six had undergone prior abdominal surgery. The patients were categorized into three chronological groups according to the procedure performed. Group 1 consisted of the first three patients in the series, whose surgery was thoracic only (robotically assisted esophagectomy). Group 2, the next three patients, had robotically assisted thoracic esophagectomy plus thoracic duct ligation using a laparoscopic gastric conduit. Group 3, the last eight patients, underwent completely robotic esophagectomy.
Results
For Group 3, the total operating room time was 11.1 ± 0.8 h (range, 11.3–13.2 h), with a console time of 5.0 ± 0.5 h (range, 4.8–5.8 h). The estimated blood loss was 400 ± 300 ml (range, 200–950 ml). One patient in group 1 had a thoracic duct leak. In groups 2 and 3, thoracic duct ligation resulted in no further leaks. Other postoperative complications included severe pneumonia (1 case), atrial fibrillation (5 cases), cervical anastomotic leak (2 cases), wound infection (1 case), and bilateral vocal cord paresis requiring tracheostomy (1 case). In seven of the cases, no intensive care unit time was required. There was one death from pneumonia 72 days after the procedure. The rate of disease-free survival was 87%.
Conclusion
The robotic approach facilitates an extended three-field esophagolymphadenectomy even after induction therapy and abdominal surgery. Larger scale trials are needed to define the role of this technique.
Similar content being viewed by others
References
Orringer MB, Sloan H (1978) Esophagectomy without thoracotomy. J Thorac Cardiovasc Surg 76: 643–654
Skinner DB (1983) En bloc resection for neoplasms of the esophagus and cardia. J Thorac Cardiovasc Surg 85: 59–71
Wang PY, Chien KY (1983) Surgical treatment of carcinoma of the esophagus and cardia among the Chinese. Ann Thorac Surg 35: 143–151
Blot WJ, Fraumeni JF Jr (1987) Trends in esophageal cancer mortality among U.S. blacks and whites. Am J Public Health 77: 296–298
Katlic MR, Wilkins EW Jr, Grillo HC (1990) Three decades of treatment of esophageal squamous carcinoma at the Massachusetts General Hospital. J Thorac Cardio Surg 99: 929–938
Collard JM, Otte JB, Fiasse R, Laterre PF, De Kock M, Longueville J, Glineur D, Romagnoli R, Reynaert M, Kestens PJ (2001) Skeletonizing en bloc esophagectomy for cancer. Ann Surg 234: 25–32
Tsurumaru M, Kajiyama Y, Udagawa H, Akiyama H (2001) Outcomes of extended lymph node dissection for squamous cell carcinoma of the thoracic esophagus. Ann Thorac Cardiovasc Surg 7: 325–329
Ando N, Iizuka T, Ide H, Ishida K, Shinoda M, Nishimaki T, Takiyama W, Watanabe H, Isono K, Aoyama N, Makuuchi H, Tanaka O, Yamana H, Ikeuchi S, Kabuto T, Nagai K, Shimada Y, Kinjo Y, Kukuda H, Japan Clinical Oncology Group (2003) Surgery plus chemotherapy compared with surgery alone for localized squamous cell carcinoma of the thoracic esophagus: a Japan Clinical Oncology Group Study–JCOG9204. J Clin Oncol 21: 4592–4596
Lerut T, Nafteux P, Moons J, Coosemans W, Decker G, De Leyn P, Van Raemdonck D, Ectors N (2004) Three-field lymphadenectomy for carcinoma of the esophagus and gastroesophageal junction in 174 R0 resections: impact on staging, disease-free survival, and outcome: a plea for adaptation of TNM classification in upper-half esophageal carcinoma. Ann Surg 240: 962–972
Hulscher JB, Tijssen JG, Obertop H, van Lanschot JJ (2001) Transthoracic versus transhiatal resection for carcinoma of the esophagus: a meta-analysis. Ann Thorac Surg 72: 306–313
Hulscher JB, Van Sandick JW, Offerhaus GJ, Tilanus HW, Obertop H, Van Lanschot JJ (2001) Prospective analysis of the diagnostic yield of extended en bloc resection for adenocarcinoma of the oesophagus or gastric cardia. Br J Surg 88: 715–719
Altorki N, Kent M, Ferrara C, Port J (2002) Three-field lymph node dissection for squamous cell and adenocarcinoma of the esophagus. Ann Surg 236: 177–183
Ando N, Ozawa S, Kitagawa Y, Shinozawa Y, Kitajima M (2000) Improvement in the results of surgical treatment of advanced squamous esophageal carcinoma during 15 consecutive years. Ann Surg 232: 225–232
Cooper JS, Guo MD, Herskovic A, Macdonald JS, Martenson JA Jr, Al-Sarraf M, Byhardt R, Russell AH, Beitler JJ, Spencer S, Asbell SO, Graham MV, Leichman LL (1999) Chemoradiotherapy of locally advanced esophageal cancer: long-term follow-up of a prospective randomized trial (RTOG 85-01). Radiation Therapy Oncology Group. JAMA 281: 1623–1627
Swanstrom LL, Hansen P (1997) Laparoscopic total esophagectomy. Arch Surg 132: 943–947
Nguyen NT, Schauer P, Luketich JD (2000) Minimally invasive esophagectomy for Barrett’s esophagus with high-grade dysplasia. Surgery 127: 284–290
Nguyen NT, Roberts P, Follette DM, Rivers R, Wolfe BM (2003) Thoracoscopic and laparoscopic esophagectomy for benign and malignant disease: lessons learned from 46 consecutive procedures. J Am Coll Surg 197: 902–913
Luketich JD, Alvelo-Rivera M, Buenaventura PO, Christie NA, McCaughan JS, Litle VR, Schauer PR, Close JM, Fernando HC (2003) Minimally invasive esophagectomy: outcomes in 222 patients. Ann Surg 238: 486–494
Horgan S, Berger RA, Elli EF, Espat NJ (2003) Robotic-assisted minimally invasive transhiatal esophagectomy. Am Surg 69: 624–626
Kernstine KH, DeArmond DT, Karimi M, VanNatta TL, Campos JC, Yoder MR, Everett JE (2004) The robotic, 2-stage, 3-field esophagolymphadenectomy. J Thorac Cardiovasc Surg 127: 1847–1849
Singh D, Maley RH, Santucci T, Macherey RS, Bartley S, Weyant RJ, Landreneau RJ (2001) Experience and technique of stapled mechanical cervical esophagogastric anastomosis. Ann Thorac Surg 71: 419–424
McKeown KC (1985) The surgical treatment of carcinoma of the esophagus: a review of the results of 478 cases. J R Coll Surg Edinb 30: 1–14
Swanson SJ, Batirel HF, Bueno R, Jaklitsch MT, Lukanich JM, Allred E, Mentzer SJ, Sugarbaker DJ (2001) Transthoracic esophagectomy with radical mediastinal and abdominal lymph node dissection and cervical esophagogastrostomy for esophageal carcinoma. Ann Thorac Surg 72: 1918–1924
Lerut TE, van Lanschot JJ (2004) Chronic symptoms after subtotal or partial oesophagectomy: diagnosis and treatment. Best Pract Res Clin Gastroenterol 18: 901–915
Altorki NK (2000) Three-field lymphadenectomy for esophageal cancer. Chest Surg Clin North Am 10: 553–560
Collard JM, Otte JB, Reynaert M, Kestens PJ (1991) Long gastroplasties with the GIA stapler in esophageal surgery. In: Ravich MM, Steichen FM, Welter R (eds) Current practice of surgical stapling. Lea & Febiger, Philadelphia, PA pp 183–187
Kernstine KH (2004) Robotics in thoracic surgery. Am J Surg 188(4A Suppl): 89S–97S
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kernstine, K.H., DeArmond, D.T., Shamoun, D.M. et al. The first series of completely robotic esophagectomies with three-field lymphadenectomy: initial experience. Surg Endosc 21, 2285–2292 (2007). https://doi.org/10.1007/s00464-007-9405-7
Received:
Revised:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1007/s00464-007-9405-7